Edition:
India

Five Prime Therapeutics Estimates Its Cash, Cash Equivalents And Marketable Securities As Of Dec 31, 2018 Was About $270.1 Mln


Monday, 7 Jan 2019 

Jan 7 (Reuters) - Five Prime Therapeutics Inc ::FIVE PRIME THERAPEUTICS - ESTIMATES ITS CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF DECEMBER 31, 2018 WAS ABOUT $270.1 MILLION.FIVE PRIME THERAPEUTICS - EXPECTS NET CASH USED IN OPERATING ACTIVITIES FOR FISCAL YEAR 2019 WILL BE BETWEEN $117 MILLION AND $122 MILLION.FIVE PRIME THERAPEUTICS - EXPECTS CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES AS OF DEC 31, 2019 WILL BE BETWEEN $148 MILLION AND $153 MILLION - SEC FILING. 

Company Quote

5.27
-0.22 -4.01%
8:10pm IST